Clinical trial · Observational
Human Papillomavirus in Young People Epidemiological Research 4
A Cross-sectional Study to Evaluate the Prevalence of HPV in Gay and Bisexual Men Aged 21-25 Years in Australia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Anal cancer is overrepresented among gay, bisexual and other men who have sex with men (MSM), particularly those living with HIV. Australia was the first country to introduce a publicly funded national HPV vaccination program in 2007. This program was expanded to include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to 15 years. The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV among 500 young gay and bisexual men aged 21-25 years who were eligible for the school-based gender-neutral quadrivalent vaccination program. Participants will be required to complete a questionnaire and provide samples for HPV testing. No follow-up visits will be required.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anal Cancer | Malignant Anal Neoplasm | CURATED_EXACT | 0.92 |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| HPV | — | UNRESOLVED | — |
| HPV 16 Infection | — | UNRESOLVED | — |
| HPV Infection | — | UNRESOLVED | — |
| Human Papillomavirus Infection | — | UNRESOLVED | — |
| Men | Multiple Endocrine Neoplasia | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Prevalence of quadrivalent vaccine HPV types
- timeFrame
- Baseline
- description
- The oral, penile and anal prevalence of quadrivalent vaccine types (6, 11, 16 and 18)
- measure
- Prevalence of type-specific HPV types
- timeFrame
- Baseline
- description
- The oral, penile and anal prevalence of type-specific HPV types
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 21 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Men aged 21 to 25 years old in 2023-2024 * Same-sex attracted * Residing in Australia since 2013 Exclusion Criteria: * Unable to complete all study requirements in English
References
Publications (0)
Data not yet available